Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive Met-enkephalin induced by intraventricular β-endorphin in the rat

[1]  Xiao-Jing Wang,et al.  Cholecystokinin octapeptide antagonized opioid analgesia mediated by μ- and κ- but not δ-receptors in the spinal cord of the rat , 1990, Brain Research.

[2]  H. H. Suh,et al.  Intrathecal administration of thiorphan and bestatin enhances the antinociception and release of Met-enkephalin induced by β-endorphin intraventricularly in anesthetized rats , 1990, Neuropeptides.

[3]  D. Mayer,et al.  Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment , 1990, Brain Research.

[4]  L. Tseng,et al.  Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice. , 1990, European journal of pharmacology.

[5]  S. Iversen,et al.  The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. , 1990, European journal of pharmacology.

[6]  H. H. Suh,et al.  Intrathecal [Met5]enkephalin antibody blocks analgesia induced by intracerebroventricular beta-endorphin but not morphine in mice. , 1989, European journal of pharmacology.

[7]  J. Fujimoto,et al.  Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice. , 1989, European journal of pharmacology.

[8]  M. Peschanski,et al.  Autoradiographic study of μ and δ opioid binding sites and neutral endopeptidase-24.11 in rat after dorsal root rhizotomy , 1989, Brain Research.

[9]  L. Tseng,et al.  Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice. , 1988, The Journal of pharmacology and experimental therapeutics.

[10]  S. Iversen,et al.  Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. , 1988, European journal of pharmacology.

[11]  J. Han,et al.  Cholecystokinin octapeptide (CCK-8): Antagonism to electroacupuncture analgesia and a possible role in electroacupuncture tolerance , 1986, Pain.

[12]  J. Fujimoto,et al.  Release of immunoreactive met-enkephalin by intraventricular beta-endorphin in anesthetized rats , 1986, Regulatory Peptides.

[13]  J. Fujimoto,et al.  Spinal release of immunoreactive Met-enkephalin by intraventricular beta-endorphin and its analogs in anesthetized rats. , 1986, The Journal of pharmacology and experimental therapeutics.

[14]  J. Fujimoto,et al.  Release of immunoreactive met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats , 1985, Brain Research.

[15]  L. Watkins,et al.  Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide , 1985, Brain Research.

[16]  L. Watkins,et al.  Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates , 1985, Brain Research.

[17]  J. Fujimoto,et al.  Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats. , 1985, The Journal of pharmacology and experimental therapeutics.

[18]  J. Fujimoto,et al.  Evidence that spinal endorphin mediates intraventricular β-endorphin-induced tail flick inhibition and catalepsy , 1984, Brain Research.

[19]  L. Watkins,et al.  Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. , 1984, Science.

[20]  B. Bunney,et al.  Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system. , 1983, Science.

[21]  L. Watkins,et al.  Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. , 1983, Science.

[22]  V. Go,et al.  Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord , 1982, Brain Research.

[23]  R. Jensen,et al.  Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Harris,et al.  The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. , 1970, The Journal of pharmacology and experimental therapeutics.

[25]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .